Pharmacia & Upjohn Company

Zoetis Services LLC

Pfizer Corporation

Zoetis P&u LLC

Pfizer Products Inc.

Shelly Lynn Shields

Jay Gregory Calvert

Siao-Kun Wan Welch

David Ewell Slade

Michael J Huether

Hans A Draayer

Omar Yousif Abdelmagid

Paul Joseph Dominowski

Richard Lee Krebs

Jeffrey E Galvin

Joseph C Frantz

Joseph Michael Bricker

Robert Greg Sorensen

Joseph Claude Frantz

Provided herein are compositions, combinations, and methods comprising Canine Respiratory Coronavirus (CRCoV), which are effective in treating or preventing respiratory infections associated secondary pathogens, such as, in animals.

Canine respiratory coronavirus for treatment and protection against bacterial infections

Provided herein are compositions comprising a canine influenza virus and a canine respiratory coronavirus. They can further comprise, pertactin, canine parainfluenza virus, and canine adenovirus serotype 2. The compositions are effective for treating or preventing canine respiratory diseases, including canine infectious respiratory disease complex.

Compositions for canine respiratory disease complex

The present invention provides methods and compositions related to the generation of host cells permissive for virus growth, particularly Porcine Reproductive and Respiratory Syndrome (PRRS) virus.

Cellular permissivity factor for viruses and uses thereof

The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.

Vaccines and methods to treat canine influenza

This invention relates to vaccines and methods for protecting dogs against disease caused by. This invention also relates to combination vaccines and methods for protecting dogs against disease or disorder caused by canine pathogens, for example, infectious tracheobronchitis caused by, canine distemper caused by canine distemper (CD) virus, infectious canine hepatitis (ICH) caused by canine adenovirus type 1 (CAV-1), respiratory disease caused by canine adenovirus type 2 (CAV-2), canine parainfluenza caused by canine parainfluenza (CPI) virus, enteritis caused by canine coronavirus (CCV) and canine parvovirus (CPV), and leptospirosis caused byor. The vaccines of the present invention include ap68 antigen.

Canine combination vaccines

The present invention relates to providing new vaccines and treatments for the diseases related to canine influenza virus. It discloses influenza viral antigens, and methods of presenting these antigens to canines, especially dogs. It relates to attenuated and killed vaccines. The present invention relates to experimentally generated canine and equine influenza viruses. The invention also includes influenza A, including H3, N8, H3N8, H7N7 and viruses which contain at least one genome segment from an canine or equine influenza virus. The present invention also relates to the use of these viruses in therapeutic compositions to protect canines, dogs in particular, from diseases caused by influenza viruses.

Growing community of inventors

Kalamazoo, MI, United States of America

Shelly Lynn Shields